Clinical trial
Assessment of the FLOTRAC/VIGILEO Third Generation Software to Predict Fluid Responsiveness in Critically Ill Patient With Acute Circulatory Failure
NCT01090791 is registered in ClinicalTrials.gov with Hôpital Européen Marseille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the FLOTRAC/VIGILEO Third Generation Software to Predict Fluid Responsiveness in Critically Ill Patient With Acute Circulatory Failure
- Lead sponsor
- Hôpital Européen Marseille
- Phase
- Observational
- Overall status
- Terminated
- Start date
- May 31, 2011
- Completion date
- September 30, 2016
- Enrollment
- 1 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute circulatory failure, critically ill, fluid loading